Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Shirin Tavana"'
Autor:
Shirin Tavana, Zahra Mokhtari, Mohammad Hossein Sanei, Zahra Heidari, Amir-Reza Dehghanian, Zahra Faghih, Marzieh Rezaei
Publikováno v:
Cancer Cell International, Vol 23, Iss 1, Pp 1-13 (2023)
Abstract Background It is well-documented that the interplay between tumor-infiltrating lymphocytes (TILs) and tumor cells is a major determining factor in cancer progression. CD45RO seems to be a reliable indicator for predicting prognosis and disea
Externí odkaz:
https://doaj.org/article/4ff064918a4442f5900d52d7b4d9d5dc
Autor:
Zahra Mokhtari, Marzieh Rezaei, Mohammad Hossein Sanei, Amirreza Dehghanian, Zahra Faghih, Zahra Heidari, Shirin Tavana
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundColorectal cancer (CRC) is a heterogeneous disease that complicates predicting patients’ prognosis and their response to treatment. CRC prognosis is influenced by the tumor microenvironment (TME). The immune system is a critical component
Externí odkaz:
https://doaj.org/article/d2749d19abd9496fb4c754247e6f9065
Autor:
Shirin Tavana, Mohammad Hossein Sanei, Zahra Mokhtari, Zahra Heidari, Zahra Sadat Faghih, Marzieh Rezaei
Background: The interplay between tumor-infiltrating lymphocytes (TILs) and tumor cells is a major determining factor in cancer progression. CD45RO seems to be a reliable indicator for predicting prognosis and disease outcome, along with CD3 and CD8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::438578484811523f01f1246f28a8ae4e
https://doi.org/10.21203/rs.3.rs-1746250/v1
https://doi.org/10.21203/rs.3.rs-1746250/v1